Photodynamic efficiency of aminolevulinic acid after two different incubation times in two cell lines

The use of aminolevulinic acid (ALA), a precursor of protoporphyrin IX (PPIX), is a new concept in PDT. The goal of our study was to compare two different incubation times of ALA in two cell lines and to evaluate phototoxic potential in correlation with extraction data of PP IX. For PDT a concentration of 1, 5, and 10 mM of ALA for Waf bladder cancer cells and 0.1, 1, and 1.5 mM for Mefa fibroblasts was used. The incubation time was 3.5 or 5.5 h. Irradiation was performed with an argon-dye laser emitting light at a wavelength of 630 nm. After irradiation, cells were incubated for two days and compared with control cells. For extraction of PP IX, cells were incubated with ALA at the same concentration as for PDT experiments for 3.5, 5.5, and 7.5 h. In both cell lines the survival rate was decreased after an incubation time of 5.5 h as compared to 3.5 h independent of the ALA-concentration or the fluence. Light and ALA alone had no effects on cells. The extraction data showed a good correlation with these results. In both cell lines the highest fluorescence of PP IX was measured after an incubation time of 5.5 h.

[1]  D. Phillips,et al.  Fluorescence distribution and photodynamic effect of ALA-induced PP IX in the DMH rat colonic tumour model. , 1992, British Journal of Cancer.

[2]  T. Hasan,et al.  Comparison of intravenous and intravesical administration of chloro-aluminum sulfonated phthalocyanine for photodynamic treatment in a rat bladder cancer model. , 1992, The Journal of urology.

[3]  J. Kennedy,et al.  Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. , 1990, Journal of photochemistry and photobiology. B, Biology.

[4]  S. Marcus,et al.  Global status of clinical photodynamic therapy: The registration process for a new therapy , 1992, Lasers in surgery and medicine.

[5]  T J Dougherty,et al.  PHOTOSENSITIZERS: THERAPY AND DETECTION OF MALIGNANT TUMORS , 1987, Photochemistry and photobiology.

[6]  J C Kennedy,et al.  Phototoxic damage to sebaceous glands and hair follicles of mice after systemic administration of 5-aminolevulinic acid correlates with localized protoporphyrin IX fluorescence. , 1990, The American journal of pathology.

[7]  S. G. Bown,et al.  Photodynamic therapy of the normal rat stomach: a comparative study between di-sulphonated aluminium phthalocyanine and 5-aminolaevulinic acid. , 1992, British Journal of Cancer.

[8]  Marie-Ange D'Hallewin,et al.  Whole bladder wall photodynamic therapy with in-situ light dosimetry for carcinoma in situ of the bladder , 1992, Photonics West - Lasers and Applications in Science and Engineering.

[9]  E Unsöld,et al.  Clinical experience with the integral photodynamic therapy of bladder carcinoma. , 1990, Journal of photochemistry and photobiology. B, Biology.

[10]  J C Kennedy,et al.  Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. , 1992, Journal of photochemistry and photobiology. B, Biology.